Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use

Details for Australian Patent Application No. 2009239536 (hide)

Owner SCHERING CORPORATION

Inventors Liu, Xiaoxiang; Mandal, Mihirbaran; Iserloh, Ulrich; Stamford, Andrew W.; Wu, Yusheng; Zhu, Zhaoning; Cumming, Jared N.; Li, Guoqing

Agent Griffith Hack

Pub. Number AU-B-2009239536

PCT Pub. Number WO2009/131975

Priority 61/047,006 22.04.08 US

Filing date 21 April 2009

Wipo publication date 29 October 2009

Acceptance publication date 28 June 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61P 25/28 Drugs for disorders of the nervous system

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/131975 Priority application(s): WO2009/131975

28 June 2012 Application Accepted

  Published as AU-B-2009239536

23 August 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 23 Jul 2012 . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009239539-Method and system for cryoablation treatment

2009239535-Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use